Technology | Breast Imaging | January 25, 2017

HealthDecision LLC Launches Personalized Breast Cancer Screening Software Tool

Software embedded within electronic health records looks at patient’s healthcare data and history to calculate individual risk for developing breast cancer in the next decade

HealthDecision, Breast Cancer Screening tool, personalized risk, UW Health, launch

January 25, 2017 — HealthDecision LLC recently announced the launch of the Breast Cancer Screening tool. This tool provides patients a personalized risk analysis for developing breast cancer in the next 10 years and the benefits or harms associated with mammogram screening.

The tool was tested and currently is used within University of Wisconsin (UW) Health, a healthcare system in the upper Midwest serving 600,000 patients each year with 1,400 physicians and 16,500 staff at six hospitals and 80 outpatient sites.

The Breast Cancer Screening tool is the result of a 2013 WI Partnership Program grant received by the UW Madison Department of Radiology and a joint effort with HealthDecision LLC to create a shared decision-making (SDM) tool that could be used at a routine appointment within a doctor's office. The project grew out of the controversy and confusion about breast cancer screening, and its multidisciplinary team included members from surgery, engineering, psychology, communications, primary care, vascular surgery research and decision making.

HealthDecision is unique in that it is embedded within the electronic health record (EHR) system and considers the patient's healthcare data and history to calculate personalized risk. Risks associated with mammogram screening include over-detection and the subsequent effects of anxiety; possible overtreatment with surgery, radiotherapy and sometimes chemotherapy; cost; and additional impacts on quality of life.

"Healthcare guidelines can be confusing to patients as well as doctors, especially when there is conflicting information in the public domain," said Sarina Schrager, M.D., UW Health and professor in the University of Wisconsin Department of Family Medicine and Community Health. Along with Beth Burnside, M.D., UW Health, who was the principle investigator on the grant, Schrager was heavily involved in the development of the tool, educating other primary care clinicians and driving the implementation strategy within UW Health primary care. "HealthDecision aids my conversation with the patient to better educate and explain the harms and benefits of a mammogram and its possible outcomes. The visualized risk analysis has been key for patients to better understand their personalized risk and increases their confidence to make better informed healthcare decisions for themselves."

The Breast Cancer Screening tool joins a suite of three other HealthDecision shared decision-making tools that provide a patient's personalized risk for the various healthcare options available:

  • The Atrial Fibrillation tool demonstrates a patient's risk of stroke or bleeding from anticoagulant medications;
  • The Cardiovascular Risk tool evaluates a patient's cholesterol and their risk of various statin medications and smoking cessation; and
  • The Lung Cancer Screening tool considers the risk for chest computed tomography (CT) scans for patients who smoke or have smoked.

For more information: www.healthdecision.org

Related Content

Breast Cancer Screening Performance Impacted by Mean Mammographic Compression Pressure
News | Mammography | December 08, 2017
Dutch researchers demonstrated a strong relationship between compression pressure in mammography and breast cancer...
Sponsored Content | Videos | Mammography | December 06, 2017
Martin Yaffe, Ph.D., FAAPM, senior scientist, physical sciences/imaging research, Sunnybrook Health Sciences Centre,
Ikonopedia and Konica Minolta Showcase Integrated Breast Imaging Workflow and Reporting at RSNA
News | Breast Imaging | December 05, 2017
Ikonopedia and Konica Minolta Healthcare Americas Inc. showcased integrated breast imaging workflow and reporting at...
Sponsored Content | Videos | Breast Imaging | December 05, 2017
Stamatia Destounis, M.D., FACR, associate professor, University of Rochester School of Medicine, attending radiologis
Numerous Studies Highlight Importance of Quantitative Breast Imaging Analysis at RSNA 2017
News | Breast Density | November 30, 2017
The importance of quantitative analysis in breast imaging was the focus of numerous abstracts accepted for presentation...
Hologic Receives FDA 510(k) Clearance of Quantra 2.2 Breast Density Assessment Software
Technology | Breast Density | November 28, 2017
Hologic Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its...
Eizo RadiForce RX560 Monitor Receives FDA 510(k) for Tomosynthesis and Digital Mammography
Technology | November 20, 2017
Eizo Corp. announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for breast tomosynthesis...
HealthMyne Highlights Value of Quantitative Data in Oncology Reads at RSNA 2017
News | Clinical Decision Support | November 17, 2017
November 17, 2017 — At the 2017 Radiological Society of North America (RSNA) conference, HealthMyne will demonstrate
Intelerad Announces Partnership With MedCurrent
News | Clinical Decision Support | November 13, 2017
November 13, 2017 — Intelerad Medical Systems announced a partnership that will see MedCurrent’s OrderWise...
Overlay Init